HUP0104510A3 - Benzofuran derivatives, their preparation and use - Google Patents

Benzofuran derivatives, their preparation and use

Info

Publication number
HUP0104510A3
HUP0104510A3 HU0104510A HUP0104510A HUP0104510A3 HU P0104510 A3 HUP0104510 A3 HU P0104510A3 HU 0104510 A HU0104510 A HU 0104510A HU P0104510 A HUP0104510 A HU P0104510A HU P0104510 A3 HUP0104510 A3 HU P0104510A3
Authority
HU
Hungary
Prior art keywords
preparation
benzofuran derivatives
benzofuran
derivatives
Prior art date
Application number
HU0104510A
Other languages
English (en)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of HUP0104510A2 publication Critical patent/HUP0104510A2/hu
Publication of HUP0104510A3 publication Critical patent/HUP0104510A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Furan Compounds (AREA)
HU0104510A 1998-12-08 1999-12-03 Benzofuran derivatives, their preparation and use HUP0104510A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11136098P 1998-12-08 1998-12-08
DKPA199801631 1998-12-09
PCT/DK1999/000676 WO2000034263A1 (en) 1998-12-08 1999-12-03 Benzofuran derivatives, their preparation and use

Publications (2)

Publication Number Publication Date
HUP0104510A2 HUP0104510A2 (hu) 2002-04-29
HUP0104510A3 true HUP0104510A3 (en) 2003-01-28

Family

ID=43768792

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104510A HUP0104510A3 (en) 1998-12-08 1999-12-03 Benzofuran derivatives, their preparation and use

Country Status (18)

Country Link
EP (1) EP1137644B9 (hu)
JP (1) JP2002531556A (hu)
AR (1) AR021509A1 (hu)
AT (1) ATE249451T1 (hu)
AU (1) AU759248B2 (hu)
CA (1) CA2353618A1 (hu)
CZ (1) CZ20012041A3 (hu)
DE (1) DE69911243T2 (hu)
DK (1) DK1137644T3 (hu)
ES (1) ES2204175T3 (hu)
HU (1) HUP0104510A3 (hu)
IL (1) IL143082A (hu)
ME (1) MEP38508A (hu)
PT (1) PT1137644E (hu)
RS (1) RS50065B (hu)
SE (1) SE1137644T5 (hu)
SI (1) SI1137644T1 (hu)
WO (1) WO2000034263A1 (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
EA008373B1 (ru) * 2000-07-07 2007-04-27 Х. Лундбекк А/С Применение эсциталопрама для лечения расстройства, связанного с посттравматическим стрессом
EA008372B1 (ru) * 2000-07-07 2007-04-27 Х.Лундбекк А/С Применение эсциталопрама для лечения расстройства, связанного с социальной тревогой
DE60110914T2 (de) * 2000-07-21 2005-10-27 H. Lundbeck A/S, Valby Verbindungen und ihre verwendung als hemmer des glycintransports
WO2002020493A2 (en) * 2000-09-06 2002-03-14 Chugai Seiyaku Kabushiki Kaisha A traceless solid-phase synthesis of 2-imidazolones
US7276603B2 (en) 2003-05-02 2007-10-02 Wyeth Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use
US7235569B2 (en) 2003-05-02 2007-06-26 Wyeth Piperidinyl indole and tetrohydropyridinyl indole derivatives and method of their use
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
EP2970177A1 (en) 2013-03-15 2016-01-20 Pfizer Inc. Indole compounds that activate ampk

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143702A (hu) * 1965-03-18
GB1173312A (en) * 1966-03-17 1969-12-10 Kefalas As Heterocyclic Compounds
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
CA2176722A1 (en) * 1993-12-28 1995-07-06 Ruth E. Ten Brink Heterocyclic compounds for the treatment of cns and cardiovascular disorders
IL114026A (en) * 1994-06-08 1999-06-20 Lundbeck & Co As H 4-aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzo thiophenemethyl) piperidines tetrahydropyridines or piperazines and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
MEP38508A (en) 2011-02-10
ATE249451T1 (de) 2003-09-15
AU1503600A (en) 2000-06-26
SI1137644T1 (en) 2003-12-31
AR021509A1 (es) 2002-07-24
DE69911243D1 (de) 2003-10-16
EP1137644A1 (en) 2001-10-04
IL143082A (en) 2004-06-20
EP1137644B1 (en) 2003-09-10
SE1137644T5 (hu) 2004-05-11
PT1137644E (pt) 2004-01-30
CZ20012041A3 (cs) 2001-10-17
EP1137644B9 (en) 2004-03-17
DK1137644T3 (da) 2003-12-08
SE1137644T3 (hu) 2003-12-02
IL143082A0 (en) 2002-04-21
CA2353618A1 (en) 2000-06-15
HUP0104510A2 (hu) 2002-04-29
DE69911243T2 (de) 2004-07-15
WO2000034263A1 (en) 2000-06-15
ES2204175T3 (es) 2004-04-16
AU759248B2 (en) 2003-04-10
YU38401A (sh) 2005-06-10
JP2002531556A (ja) 2002-09-24
RS50065B (sr) 2009-01-22

Similar Documents

Publication Publication Date Title
IL141479A0 (en) Substituted phenyl derivatives, their preparation and use
HK1048999A1 (zh) 氮雜䓬吲衍生物,它們的製備和應用
IL139286A0 (en) Polyol-ifn-beta conjugates, their preparation and use
PL351312A1 (en) New compounds, their preparation and use
HK1042084A1 (en) Substituted benzimidazoles and their preparation and use.
AU6325599A (en) New compounds, their preparation and use
AU6190199A (en) New compounds, their preparation and use
AU6190299A (en) New compounds, their preparation and use
AU6325699A (en) New compounds, their preparation and use
PL351250A1 (en) Antipicornaviral compounds, their preparation and use
IL150241A0 (en) Substituted phenyl-piperazine derivatives, their preparation and use
IL135451A0 (en) 3-amino-3-arylpropan-1-ol derivatives, their preparation and use
AU3595099A (en) New compounds, their preparation and use
ZA989664B (en) 3-substituted tetrahydropyrimidinone derivatives, their preparation and use.
IL143082A0 (en) Benzofuran derivatives, their preparation and use
HUP0104819A3 (en) Chroman derivatives, their use intermediate and process for their preparation
IL135452A0 (en) 3-amino-3-arylpropan-1-ol derivatives, their preparation and use
GB2332671B (en) Acetals, their preparation and their use
HK1028595A1 (en) Substituted cycloheptenes, their preparation and use
PL347934A1 (en) Benzofuran derivatives, their preparation and use
HUP0203678A3 (en) Nitro-sulfobenzamide-derivatives, preparation and use thereof
HUP0203455A3 (en) 2-arylquinoline derivatives, preparation and therautic use thereof
AU3700899A (en) New compounds, their preparation and use
SI1073672T1 (en) Antipicornaviral compounds, their preparation and use
SI1123274T1 (en) Substituted phenyl derivatives, their preparation and use

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished